The economics of eradicating Helicobacter pylori infection in duodenal ulcer disease

American Journal of Medicine

Volumn 100, Issue 5 A, 1996, Pages 60S-64S

  Vakil, N ^a   Fennerty, B ^a   Freston, J ^a   Hunt, R ^a   Ganz, R ^a   Barkin, J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BISMUTH DERIVATIVE; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ANTIBIOTIC THERAPY; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DRUG COST; DUODENUM ULCER; ECONOMIC ASPECT; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; INTESTINE INFECTION; PRIORITY JOURNAL; ANTIBIOTIC RESISTANCE; DRUG COMBINATION; ECONOMICS; HEALTH CARE COST; HELICOBACTER INFECTION; MICROBIOLOGY; REVIEW; STATISTICAL MODEL; UNITED STATES;

DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; DUODENAL ULCER; HEALTH CARE COSTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MODELS, ECONOMIC; UNITED STATES;

EID: 85048352842     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. National Health Interview Survey. US Department of Health and Human Services, Public Health Service, Centers for Disease Control. National Center for Health Statistics, Hyattsville, Maryland, 1990.
2. A Sonnenberg Peptic ulcer in digestive diseases in the United States: epidemiofogy and impact JE Everhart US Department of Health and Human Services, Public Health Service, National Institutes of Health 1994 359 382
3. EJ Graves Summary: National Hospital Discharge Survey. National Center for Health Statistics Advance Data 227 1993 1 10
4. A Sonnenberg W Townsend Casts of duodenal ulcer therapy with antibiotics Arch Intern Med 155 1995 922 928
5. B O'Brien R Goeree A Maharned RH Hunt Cost effectiveness of Heficobatter pylori eradication for the long-term management of duodenal ulcer in Canada Arch intern Med 155 1995 1958 1964
6. N Vakil MB Fennerty Economic modeling of medical therapy for Helicobacter pylori related peptic ulcer disease Am J Gastroenterol 91 1996 239 245
7. P Davey A Craig F Murray M Malek A decision analysis of healthcare costs following eradication of Helicobacter pylori with omeprazole in combination with either amoxicillin or clarithromycin Get 37 suppl 1 1995 A47
8. PM Rothwell Can overall results of clinical trials be applied to all patients? Lancet 345 1995 1616 1619
9. R Horwitz S Howitz Adherence to treatment and health outcomes Arch Intern Med 153 1993 1863 1868
10. DY Graham GM Lew HM Malaty Factors influencing the eradication of Helicobacter pylori with triple therapy Gastroenterology 102 1992 493 496
11. CA Fallone AN Barkun V Loo Compliance, selection of treatment and the absence of duodenitis are predictors of successful eradication of Helicobacter pylori Gastroenterology 108 part 4 suppl 1995 A91
12. GD Bell K Powell SM Burridge Experience with “triple” anti- Helicobatter pylori eradication therapy: side-effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance Aliment Pharmacol Ther 6 1992 427 435
13. JX Lian J Carrick A Lee G Daskalopoulos Metroraidazole resistance significantly affects eradication of H. pylori infection Gastroenterology 104 suppl 1993 A133
14. CA McNulty JC Dent Susceptibility of clinical isolates of Camplyobacter pylori to twenty-one anti-microbial agents Eur J Clin Microbiol Infect Dis 7 1988 566 569
15. F Mégraud Helicobacter pylori resistance to antibiotics RH Hunt GNJ Tytgat Helicobacter pylori : Basic Mechanisms to Clinical Cure 1994 Kluwer Academic Publishers Dordrecht 570 583
16. N Banatvala G Davies Y Abdi high prevalence of Helicobacter pylori metronidazole resistance in migrants to East London: relation wth previous nitroimidazole exposure and gastroduodenal disease Gut 35 1994 1562 1566
17. E Bayerdorffer G Mannes A Sommer High dose omeprazole treatment combined with amaxiciilin eradicates Helicobacter pylori Eur J Hepatogastroenterol 41 1994 43 47
18. K Graham H Malaty H El-Zimiaty Variability with omeprazole-amoxicillin combination for the treatment of Helicobacter pylori infection Am J Gastroenterol 90 1995 1415 1419
19. D Kessler J Rose R Temple Therapeutic-class-wars-drug promotion in a competitive market place N Engl J Med 331 1994 1350 1353
20. Anon Suggested guidelines for the managment of peptic ulcer disease, GERD, H. pylori 1994 Connecticare Inc.
21. D Asch J Hershey Why some health policies don't make sense at the bedside Ann Intern Med 122 1995 846 850